Dean Y. Li - 01 Oct 2021 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Nathan Hatfield, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
01 Oct 2021
Net transactions value
$0
Form type
4
Filing time
05 Oct 2021, 20:24:07 UTC
Previous filing
06 Jul 2021
Next filing
09 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +543 +0.09% $0.000000 597,263 01 Oct 2021 Direct F1
holding RXRX Class A Common Stock 1,422,048 01 Oct 2021 By Dean Li and Ruth Li Revocable Trust
holding RXRX Class A Common Stock 450,000 01 Oct 2021 By Dean Y. Li 2021 2021 Family Trust
holding RXRX Class A Common Stock 1,350,000 01 Oct 2021 By Dean Y. Li 2021 2021 GRAT
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.